Comparative Analysis of Radiation Response in Chemo-Treated BT20, 4T1 Breast Cancer, and Neuroblastoma Cancer Cell Lines through Single and Multiple Cell Ionization Using Infrared Laser Trapping

Author:

Goangul Mulugeta S.1,Chen Li2,Gao Ying3,Erenso Daniel3,Eshun Kwame4,Alvarez Gisela5,Crogman Horace T.5

Affiliation:

1. Addis Ababa University

2. Guangxi University of Science and Technology

3. Middle Tennessee State University

4. Sierra College

5. California State University Dominguez Hills

Abstract

Abstract The aim of our study was to use laser trapping technique to evaluate the radiation sensitivity of cancer cells, both untreated and chemo-treated. We focused on a specific human breast tumor cell line, called BT20, that was treated with an antitumor compound known as 2-Dodecyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione. We investigated an untreated control group, as well as two groups of BT20 cells that were subjected to different treatment durations. We utilized a high-power infrared laser (at 1064 nm) trap to determine the absorbed threshold ionization energy (TIE) and threshold radiation dose (TRD) for single and multiple cells trapping and ionization. We performed statistical analyses, including descriptive and one-way ANOVA, on the results. We also analyzed the relationship between TIE and TRD to the mass of the individual cells for different hours of treatment, in comparison to the control group. Our findings revealed that both TIE and TRD decreased as treatment duration increased. However, the TRD decreased with mass irrespective of the treatment. Moreover, our analyses consistently showed the same behavior of TRD for single vs. multiple cell ionizations within each group, regardless of treatment. In addition, we conducted a comparative analysis on the effects of radiation dosage in BT20, 4T1 breast cancer, and N2a neuroblastoma cell lines, and discovered that the TRD decreased in mass across all three cell lines.

Publisher

Research Square Platform LLC

Reference52 articles.

1. World Health Organization. Global Health Observatory. Geneva: World Health Organization; 2019. who.int/gho/database/en/. Accessed June 21, 2019.

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: A Cancer Journal for Clinicians,2018

3. Bauer, Katrina R., Monica Brown, Rosemary D. Cress, Carol A. Parise, and Vincent Caggiano. "Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype: a population‐based study from the California cancer Registry." cancer 109, no. 9,1721–1728, (2007).

4. Sugita, Bruna, Mandeep Gill, Akanskha Mahajan, Anju Duttargi, Saurabh Kirolikar, Rodrigo Almeida, Kenny Regis et al. "Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women." Oncotarget 7, no. 48 (2016): 79274.

5. Cancer and radiation therapy: current advances and future directions;Baskar R;Int J Med Sci.,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3